Nirad
Nirad Jain is a partner in Bain & Company's New York office. He co-leads Bain’s global Healthcare Private Equity and Corporate M&A practices.
Nirad has almost 20 years of management consulting experience, partnering with corporate clients and financial investors to drive results. He has led more than 200 client engagements across the healthcare value chain, including diligence, corporate M&A, transformation, performance improvement and strategy work in the services, payer, provider, medical device and pharmaceuticals sectors.
He has built significant expertise at the intersection of private equity and healthcare and is frequently cited in the media, including appearances on Bloomberg TV, The New York Times, The Wall Street Journal, Reuters, CNBC, Forbes, Buyouts and many others around the globe.
Prior to joining Bain in 2005, Nirad worked for another consulting confirm in New York, where he advised clients on growth and M&A strategies. He also previously worked in the not-for-profit sector.
Nirad holds an MBA from The Wharton School, a Master of Science from Stanford University and a Bachelor of Science, with honors, from Columbia University.
Recent Insights
- “Welcome Letter: Fertile Conditions for Healthcare Private Equity Investment,” Report, 2021년3월17일
- “Healthcare Private Equity Market 2020: The Year in Review,” Report, 2021년3월17일
- “The Covid-19 Paradox: Widespread Repercussions for Demand, but New Healthcare Investment Opportunities as Well,” Report, 2021년3월17일
- “Healthcare Private Equity in North America: Bring On the Gem Assets,” Report, 2021년3월17일
- “Healthcare Providers: New Roll-Up Candidates and a New Look for Risk-Bearing Providers,” Report, 2021년3월16일
- “Healthcare Payers: A Bid to Reduce Costs for Patients and Employers,” Report, 2021년3월16일
- “Biopharma: Commercialization Support Services Are Thriving ,” Report, 2021년3월16일
- “Medtech: Four Themes Fueled Deals despite the Pandemic,” Report, 2021년3월16일
- “Healthcare IT: Technologies Help Improve Patient Experiences at Lower Costs,” Report, 2021년3월16일
- “Healthcare M&A: A Pandemic-Induced Slowdown in Every Sector,” Report, 2021년3월16일
In the News
- “Healthcare private equity buyouts posted record-setting volumes in 2020 after a year of unprecedented upheaval for global healthcare,” Press release, 2021년3월16일
- “Private-Equity Firms Plow Record Amounts Into Biopharmaceutical Sector,” WSJ Pro Private Equity, 2020년3월8일, 헬스케어
- “Healthcare to Remain a Hotbed for PE Dealmaking: Bain & Company,” The Deal, 2019년4월22일, 헬스케어
- “Cooper’s Take: Midterm Results May Lead to More Stability for Health-Care Investors,” WSJ Pro , 2018년11월9일, 사모펀드
- “U.S. regulators snip red tape for medical devices to curb opioid crisis,” Reuters, 2018년11월9일, 헬스케어